MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 72 filers reported holding MILLENDO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 9.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $324,000 | -7.4% | 199,000 | 0.0% | 0.05% | -13.1% |
Q2 2020 | $350,000 | -89.2% | 199,000 | -67.5% | 0.06% | -92.9% |
Q1 2020 | $3,231,000 | -21.7% | 611,900 | 0.0% | 0.86% | +6.3% |
Q4 2019 | $4,124,000 | +359.8% | 611,900 | +688.2% | 0.81% | +368.6% |
Q2 2019 | $897,000 | +199.0% | 77,629 | +288.1% | 0.17% | +191.5% |
Q1 2019 | $300,000 | +88.7% | 20,000 | 0.0% | 0.06% | +68.6% |
Q4 2018 | $159,000 | – | 20,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,396,615 | $9,930,000 | 3.10% |
NEA Management Company, LLC | 1,766,779 | $12,562,000 | 1.04% |
Samsara BioCapital, LLC | 186,540 | $1,326,000 | 0.90% |
GREAT POINT PARTNERS LLC | 1,288,093 | $9,158,000 | 0.84% |
Bpifrance SA | 1,078,670 | $7,669,000 | 0.83% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $1,264,000 | 0.58% |
ADAMS STREET PARTNERS LLC | 367,935 | $2,616,000 | 0.52% |
Prosight Management, LP | 52,051 | $370,000 | 0.20% |
GMT CAPITAL CORP | 53,419 | $380,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 38,881 | $276,000 | 0.00% |